Galectin Therapeutics Inc. (GALT) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 15.69M | 19.44M | 12.73M | 15.43M | 9.29M | 17.25M | 28.67M | 27.29M | 25.46M | 27.71M | 21.61M | 19.47M | 19.55M | 20.55M | 17.12M | 25.79M | 33.51M | 41.82M | 38M | 33.33M |
| Cash & Short-Term Investments | 14.11M | 17.72M | 11.53M | 13.77M | 7.43M | 15.12M | 27.06M | 25.6M | 23.55M | 25.66M | 20.36M | 17.97M | 17.8M | 18.59M | 15.83M | 24.18M | 31.61M | 39.65M | 36.6M | 31.6M |
| Cash Only | 14.11M | 17.72M | 11.53M | 13.77M | 7.43M | 15.12M | 27.06M | 25.6M | 23.55M | 25.66M | 20.36M | 17.97M | 17.8M | 18.59M | 15.83M | 24.18M | 31.61M | 39.65M | 36.6M | 31.6M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.58M | 1.72M | 1.2M | 1.66M | 1.85M | 2.13M | 1.61M | 0 | 1.91M | 2.05M | 1.25M | 1.5M | 1.75M | 1.96M | 1.29M | 1.61M | 0 | 2.17M | 1.4M | 1.74M |
| Total Non-Current Assets | 68K | 96K | 136K | 175K | 243K | 243K | 306K | 368K | 430K | 490K | 552K | 613K | 673K | 733K | 793K | 101K | 108K | 7K | 40K | 71K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35K | 45K | 53K | 62K | 70 | 673K | 0 | 0 | 101K | 108K | 0 | 18K | 28K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 68K | 96K | 136K | 175K | 243K | 243K | 306K | 333K | 385K | 437K | 490K | 612.93K | 0 | 733K | 793K | 0 | 0 | 7K | 22K | 43K |
| Total Assets | 15.76M | 19.53M | 12.87M | 15.6M | 9.53M | 17.5M | 28.97M | 27.66M | 25.89M | 28.2M | 22.16M | 20.08M | 20.23M | 21.29M | 17.91M | 25.89M | 33.62M | 41.83M | 38.04M | 33.41M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 65.4% | 11.64% | -55.6% | -43.58% | -63.2% | -37.96% | 30.72% | 37.72% | 28.01% | 32.49% | 23.72% | -22.43% | -39.83% | -49.11% | -52.91% | -22.51% | 46.81% | 41.31% | 11.72% | -19.15% |
| Total Current Liabilities | 7.31M | 8.03M | 136.44M | 10.77M | 110.84M | 35.41M | 25.26M | 14.62M | 12.63M | 15.68M | 10.52M | 9.95M | 11.53M | 13.01M | 9.59M | 10.89M | 9.54M | 9.03M | 8.3M | 6.05M |
| Accounts Payable | 3.12M | 3.25M | 5.39M | 5.87M | 6.53M | 5.66M | 2.79M | 3.7M | 3.8M | 6.43M | 2.68M | 1.98M | 2.55M | 3.89M | 2.35M | 2.96M | 1.91M | 1.8M | 1.92M | 924K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 6K | 0 | 122.28M | 0 | 97.11M | 21.12M | 10.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.18M | 4.7M | 4.84M | 844K | 852K | 1.89M | 1.42M | 63K | 518K | 8.07M | 857K | 7.29M | 386K | 8.11M | 751K | 7.38M | 300K | 6.49M | 520K | 4.73M |
| Current Ratio | 2.15x | 2.42x | 0.09x | 1.43x | 0.08x | 0.49x | 1.13x | 1.87x | 2.02x | 1.77x | 2.05x | 1.96x | 1.70x | 1.58x | 1.79x | 2.37x | 3.51x | 4.63x | 4.58x | 5.51x |
| Quick Ratio | 2.15x | 2.42x | 0.09x | 1.43x | 0.08x | 0.49x | 1.13x | 1.87x | 2.02x | 1.77x | 2.05x | 1.96x | 1.70x | 1.58x | 1.79x | 2.37x | 3.51x | 4.63x | 4.58x | 5.51x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 138.69M | 137.7M | 1.72M | 122M | 10.95M | 85.16M | 96.19M | 95.19M | 84.34M | 72.77M | 62.51M | 61.26M | 51.34M | 40.47M | 30.66M | 30.22M | 30.27M | 30.18M | 20.49M | 10.23M |
| Long-Term Debt | 135.71M | 133.74M | 0 | 120.46M | 10.81M | 85.11M | 94.04M | 93.42M | 82.46M | 71.74M | 61.14M | 60.36M | 49.94M | 39.83M | 29.73M | 29.5M | 29.27M | 29.05M | 19.3M | 9.64M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 20K | 32K | 0 | 55K | 0 | 77K | 87K | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.98M | 3.96M | 1.72M | 1.54M | 136K | 47K | 2.16M | 1.76M | 1.87M | 1M | 1.34M | 896K | 1.34M | 639K | 850K | 626K | 998K | 1.13M | 1.19M | 592K |
| Total Liabilities | 146M | 145.73M | 138.17M | 132.77M | 121.79M | 120.56M | 121.45M | 109.8M | 96.98M | 88.44M | 73.04M | 71.21M | 62.87M | 53.48M | 40.25M | 41.11M | 39.81M | 39.21M | 28.79M | 16.29M |
| Total Debt | 135.71M | 133.74M | 122.31M | 120.51M | 107.99M | 106.25M | 104.59M | 93.47M | 82.52M | 71.81M | 61.22M | 60.4M | 50.04M | 39.87M | 29.85M | 29.62M | 29.29M | 29.06M | 19.32M | 9.67M |
| Net Debt | 121.6M | 116.02M | 110.79M | 106.74M | 100.56M | 91.13M | 77.53M | 67.87M | 58.96M | 46.15M | 40.85M | 42.44M | 32.24M | 21.28M | 14.02M | 5.44M | -2.32M | -10.59M | -17.28M | -21.92M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.11x | 2.09x | 0.57x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.05x | -1.84x | -3.50x | -3.12x | -4.52x | -5.94x | -6.51x | -8.75x | -9.92x | -10.80x | -11.49x | -13.02x | -24.06x | -33.53x | -30.96x | -40.98x | -42.75x | -25.55x | -75.76x | -98.40x |
| Total Equity | -130.24M | -126.19M | -125.3M | -117.17M | -112.26M | -103.07M | -92.48M | -82.15M | -71.09M | -60.24M | -50.87M | -51.13M | -42.65M | -32.19M | -22.34M | -15.22M | -6.19M | 2.62M | 9.25M | 17.12M |
| Equity Growth % | -16.01% | -22.44% | -35.49% | -42.63% | -57.92% | -71.1% | -81.79% | -60.67% | -66.69% | -87.12% | -127.77% | -235.85% | -588.62% | -1330.66% | -341.49% | -188.94% | -133.96% | -89.19% | -70.68% | -53.75% |
| Book Value per Share | -1.98 | -1.97 | -1.95 | -1.85 | -1.78 | -1.64 | -1.48 | -1.32 | -1.15 | -1.00 | -0.85 | -0.86 | -0.72 | -0.54 | -0.38 | -0.26 | -0.10 | 0.04 | 0.16 | 0.29 |
| Total Shareholders' Equity | -130.24M | -126.19M | -125.3M | -117.17M | -112.26M | -103.07M | -92.48M | -82.15M | -71.09M | -60.24M | -50.87M | -51.13M | -42.65M | -32.19M | -22.34M | -15.22M | -6.19M | 2.62M | 9.25M | 17.12M |
| Common Stock | 65K | 65K | 64K | 63K | 63K | 62K | 62K | 62K | 61K | 61K | 61K | 59K | 59K | 59K | 59K | 59K | 59K | 59K | 59K | 59K |
| Retained Earnings | -437.61M | -432.55M | -426.98M | -418.76M | -411.18M | -401.57M | -389.54M | -378.3M | -365.87M | -354.37M | -344.31M | -330.27M | -321.09M | -309.57M | -298.87M | -290.29M | -280.61M | -270.69M | -263.41M | -254.85M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -61K | 0 | -510K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |